Tiotropium Outperforms Salmeterol in Moderate COPD - Physician's First Watch
Links shared publicly online about this topic.
- 415total visits
Tiotropium Outperforms Salmeterol in Moderate COPD - Physician's First Watch
The anticholinergic drug tiotropium is more effective at forestalling exacerbations in chronic obstructive pulmonary disease than the beta-2 agonist salmeterol, according to a New England Journal of Medicine study. International researchers (including employees of tiotropium's . . . LINK(S):
View full resource at firstwatch.jwatch.org
Tags: Asthma Medication, COPD, COPD Medication, Drug, Spiriva, Serevent, Physician
Most Recently Shared on March 25, 2011 at 1:17 am By:
Tiotropium Outperforms Salmeterol in Moderate COPD - http://icio.us/PNudqL
Tiotropium vs. Salmeterol for COPD Exacerbations - QualityPoint Technologies
qualitypointtech.net — “Both inhaled long-acting beta-agonists and inhaled anticholinergic agents are first-line treatments for patients with moderate-to-severe chronic obstructive pulmonary disease. Which is better? Journal Watch” View full resource at qualitypointtech.net
Most Recently Shared on April 13, 2011 at 10:35 am By:
Tiotropium vs. Salmeterol for COPD Exacerbations: Both inhaled long-acting beta-agonists and inhaled anticholinerg... http://bit.ly/ffaGpD
Advertisement
